ExeVir Bio Competitors and Similar CompaniesClear all

ExeVir Bio's competitors and similar companies include Chrysalis BioTherapeutics and StrideBio.
ExeVir Bio
ExeVir Bio
ExeVir Bio is a company that harnesses a llama-derived antibody technology platform to generate antiviral therapies providing broad protection against coronaviruses.
Chrysalis BioTherapeutics
Chrysalis BioTherapeutics
ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs.
StrideBio
StrideBio
StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.
Founding Date
Founding Date
2020
Founding Date
2012
Founding Date
2015
Type
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Gent, BE HQ
Locations
Galveston, US HQ
Locations
US HQ
Employees
Employees
1611% decrease
Employees
6
Employees
5

Funding

Latest funding round
Latest funding round
$ 23m (about 5 years ago)
Latest funding round
$ 10.4m (over 5 years ago)
Latest funding round
$ 81.5m (about 5 years ago)
Total funding raised
Total funding raised
$ 50m
Total funding raised
$ 11m
Total funding raised
$ 97.2m
For sources of this data, please see the company profile

View Company Profiles

Chrysalis BioTherapeutics
HQ
Galveston, US
Employees
6

ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs.

View company
StrideBio
HQ
US
Employees
5

StrideBio is a gene therapy company focused on creating and developing novel adeno-associated viral vector technologies and therapeutics for rare diseases.

View company